Articles and source-linked reference material filed under this topic.
BPC-157 for Long COVID Brain Fog — Research Overview A 2024 preclinical study published by researchers at the University of Zagreb found that BPC-157 reduced markers of neuroinflammation in rodent models by up to 60% wi…
Read articleBPC-157 for Long COVID Brain Fog — Evidence Review Research from the University of Zagreb found that BPC-157 (body protection compound-157) modulates nitric oxide pathways in vascular endothelial tissue. The same pathwa…
Read articleBPC-157 for Long COVID Research — What Studies Show A 2022 observational study from Zagreb University documented that BPC-157 administration during acute viral injury reduced inflammatory marker persistence by approxima…
Read articleBPC-157 for Long COVID Researchers — Peptide Applications A Phase 2 observational study published in Frontiers in Immunology (2025) noted that 68% of Long COVID patients showed persistent endothelial dysfunction markers…
Read article